Bahrain's sovereign wealth fund Mumtalakat and SandboxAQ announced a strategic partnership expected to generate more than $1 billion in new biotech assets for the Kingdom. Under a three-year program, Bahrain will license SandboxAQ's quantitative AI software, tools that use physics and chemistry equations to model molecules, to identify and develop drug targets and new therapeutics. The deal is intended to position Bahrain as a regional biotech hub, extending SandboxAQ's drug-discovery technology into sovereign-backed research infrastructure. SandboxAQ is a Parkway Venture Capital portfolio company.
Read the full article: SandboxAQ's partnership announcement
Share
Greatness lies ahead
Sign up for updates from the cutting edge of deep tech venture capital.
You’re on the list!
Something went wrong while submitting the form.
